These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3500580)

  • 1. Cytotoxic lymphocytes in human intestinal mucosa.
    Shanahan F; Brogan M; Nayersina R; Targan S
    Adv Exp Med Biol; 1987; 216A():457-63. PubMed ID: 3500580
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of lymphokines in the generation of cytotoxic T lymphocytes].
    Kasakura S
    Rinsho Ketsueki; 1984 Apr; 25(4):479-87. PubMed ID: 6236311
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of soluble cytotoxic factors in lymphokine-activated killer cell (LAK)-mediated cytotoxicity.
    Hiserodt JC; Chambers WH
    Ann N Y Acad Sci; 1988; 532():395-404. PubMed ID: 3052213
    [No Abstract]   [Full Text] [Related]  

  • 4. Alloselective natural killer cells are activated by allogeneic heart transplantation and can potentially play a functional role as classic CTLs.
    Petersson E; Ostraat O; Hansson J; Ekberg H; Brodin T; Dohlsten M; Hedlund G
    Transplant Proc; 1994 Jun; 26(3):1732-3. PubMed ID: 8030109
    [No Abstract]   [Full Text] [Related]  

  • 5. Nonspecific recruitment of cytotoxic effector cells in the intestinal mucosa of antigen-primed mice.
    Klein JR; Kagnoff MF
    J Exp Med; 1984 Dec; 160(6):1931-6. PubMed ID: 6334717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontogeny of the Thy-1-, Lyt-2+ murine intestinal intraepithelial lymphocyte. Characterization of a unique population of thymus-independent cytotoxic effector cells in the intestinal mucosa.
    Klein JR
    J Exp Med; 1986 Jul; 164(1):309-14. PubMed ID: 2873198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of natural killer cells to the allograft response.
    Hoffman RA; Jordan ML; Ascher NL; Simmons RL
    Transplant Proc; 1988 Apr; 20(2):186-8. PubMed ID: 3259031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD56 adhesion molecule is the major determinant for detecting non-major histocompatibility complex-restricted cytotoxic mononuclear cells from the intestinal lamina propria.
    Van Tol EA; Verspaget HW; Peña AS; Kraemer CV; Lamers CB
    Eur J Immunol; 1992 Jan; 22(1):23-9. PubMed ID: 1370415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraepithelial lymphocytes of human gut: isolation, characterisation and study of natural killer activity.
    Cerf-Bensussan N; Guy-Grand D; Griscelli C
    Gut; 1985 Jan; 26(1):81-8. PubMed ID: 3871194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effector mechanisms against neuroblastoma cells and their modulation by lymphokines.
    Iwami T; Yamashita U; Nakamura H; Yamagishi M
    Acta Paediatr Jpn; 1988 Aug; 30(4):483-91. PubMed ID: 3150239
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection and characterization of cytotoxic T lymphocyte precursors in the murine intestinal intraepithelial leukocyte population.
    Ernst PB; Clark DA; Rosenthal KL; Befus AD; Bienenstock J
    J Immunol; 1986 Mar; 136(6):2121-6. PubMed ID: 2936822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on lymphokine activated killer cells in the rat: analysis of precursor and effector cell phenotype and relationship to natural killer cells.
    Hiserodt JC; Vujanovic NL; Reynolds CW; Herberman RB; Cramer DV
    Prog Clin Biol Res; 1987; 244():137-46. PubMed ID: 2958869
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphokine-activated and natural killer cell activity in human intestinal mucosa.
    Hogan PG; Hapel AJ; Doe WF
    J Immunol; 1985 Sep; 135(3):1731-8. PubMed ID: 3926882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic lymphocytes and intestinal disease.
    James SP; Strober W
    Gastroenterology; 1986 Jan; 90(1):235-7. PubMed ID: 3484384
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective growth of natural cytotoxic but not natural killer effector cells in interleukin-3.
    Djeu JY; Lanza E; Pastore S; Hapel AJ
    Nature; 1983 Dec 22-1984 Jan 4; 306(5945):788-91. PubMed ID: 6197655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic activity of T cells expressing different T-cell receptor variable gene products in the intestinal mucosa.
    Baca-Estrada ME; Croitoru K
    Adv Exp Med Biol; 1995; 371A():151-2. PubMed ID: 8525895
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural cytotoxic activity in murine and human systems. A review.
    Lattime EC
    Year Immunol; 1986; 2():261-6. PubMed ID: 3554823
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunology. Stimulating killer cells.
    Bevan MJ
    Nature; 1989 Nov; 342(6249):478-9. PubMed ID: 2586621
    [No Abstract]   [Full Text] [Related]  

  • 19. Heterogeneity of cytotoxic lymphocytes potentially relevant for cellular immunotherapy of cancer: implications for designing clinical strategies.
    Triebel F; Hercend T
    Prog Clin Biol Res; 1987; 244():207-11. PubMed ID: 3498949
    [No Abstract]   [Full Text] [Related]  

  • 20. OK-432 and IL-2-augmented cytotoxicity of human natural killer cells and cytotoxic T lymphocytes at the clonal level.
    Gravekamp C; Vreugdenhil R; Bolhuis RL
    FEMS Microbiol Immunol; 1988 Jan; 1(1):31-9. PubMed ID: 2978812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.